U.S. Markets closed

Intellicheck, Inc. (IDN)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
3.39-0.08 (-2.31%)
At close: 4:00PM EDT
People also watch
GVPISRINSVIIIGC
  • I have tripled my money since investing around two years ago. Sorry.
  • Has this company ever had a profitable quarter? Ever?

    Investors have lost 97% of their original investment.

    Company keeps posting about sales to retail companies. All I read about in this age of Amazon is closing retail stores and locations.
  • Another fake news (about 5 US banks) by Roof & Co. - why not to disclose this is a simple renew of SaaS of an existing, old account IDN had for years?
  • Hey back to the future..... Intellicheck renames itself Intellicheck.... they sure did bang up business last time they were named Intellicheck....

    Now they can go out and spend what little precious cash they have on all new stationary and signage
  • While imitation is the greatest form of flattery.... is this space its flatulence
  • Dr. Roof hired Indian sweet shop to design secure solutions for US government and businesses. Great cost cutting measures, shareholders applaud this move!
  • Intellicheck has been in business so long their core patents have expired. During that time they have never been profitable. Not once. I listened to the conference call. Management is living in an alternate reality. They also will not fair well at the mediation in May with Honeywell concerning the patent dispute. Honeywell will not settle and will not pay one dime to Intellicheck.
  • As always, listen to the conference call.

    Book of business building solidly, delay in revenue realization because of security audits by clients taking longer than anticipated.

    Profitability forecast for end of year 2017 or Q1 2018.
  • I guarantee IDN will not be profitable this year or any time soon.
  • Check out miteksystems.com. Stock symbol MITK. They are the leader in the financial space for mobile driver's license authentication, on-boarding, and fraud prevention.
  • Promises, promises....

    It never ends.
  • Can someone explain this surge in the stock price, Please
  • Can anyone explain the huge surge in price and volume today? Nothing in it earnings release warranted such a reaction.
  • IDN has a difficult quarterly comparison coming up....

    Last Q they compared Q3 revs to Q2 16 and said the were were an astounding increase while ignoring they were a dramatic drop from Q3 15 to which they should have been compared

    The upcoming LP$ Does not give them that opportunity.... they are up against $1.5 mil Q4 15 revs and $1.3 mil Q 3 15 revs.....

    Thats just the facts..... IDN would need to do $2 mil in Q4 rev to sustain the growth comparison that they created
  • 10 % growth today up .30 a share. News coming
  • Seems like someone has news, stock is surging with 7 + % increase in price and a double in transactions, It will be an interesting day
  • Why do they keep losing key customers? I just learned that LexisNexis dumped IDN and went with solutions from Acuant. What is going on here? Is the company just going to lose all old customers since their ID scanning patents expired in August of this year?
  • Intellicheck Mobilisa Announces Third Quarter 2016 Financial Results

    From the press release today: Revenues Increase 29% While Expenses Decrease 34%

    Now THAT's the kind of press release we like to see
  • VSUL is the company that is going to give IDN the ability to do real time identity and material authentication in the f

    Visualant™ is a public company whose shares trade under the stock symbol “VSUL.” The Visualant Spectral Pattern Matching™ (SPM) technology directs structured light onto a substance or material, through a liquid or gas, or off a surface, to capture a unique ChromaID™. A ChromaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented, award-winning technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests.